Machine Learning

A new software-defined radio isn't just a product launch; it's a strategic masterstroke, embracing open standards to reshape electronic warfare and investment.

A California fragrance brand conquered Korea and now targets the U.S. We dissect the data-driven strategy and AI's quiet role in its rapid rise.

A new platform lets your idle devices earn Bitcoin. Is this a futuristic lifestyle trend for luxury living or just a volatile digital experiment?

A regulatory filing from Balyasny Asset Management reveals intense investor activity as a bidding war for narcolepsy drugmaker Avadel heats up.

Cleric's new AI SRE agent promises to end engineering firefighting by learning from incidents. With $9.8M in funding, is this the future of system reliability?

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

Regenerative Patch Technologies advances its stem cell therapy for dry AMD, signaling a potential shift from merely slowing blindness to actively improving vision.

A regulatory filing from Weiss Asset Management reveals a complex arbitrage play on Alphawave IP, spotlighting its critical role in the Qualcomm deal.

A $2.4B tech acquisition seems distant from healthcare, but Qualcomm's move to buy Alphawave is building the essential AI infrastructure for medicine's future.

With a new M&A-savvy CRO and Blackstone's backing, Enverus is poised for aggressive growth, aiming to dominate the AI-driven future of energy intelligence.

Indian engineering giant Cyient opens a Lisbon innovation center, signaling a major strategic push to dominate Europe's network modernization race with AI and 5G.

Ledger Investing launches Korra, a battle-tested SaaS platform using AI to bring transparency and efficiency to the complex casualty ILS market.

Rockwell Automation's new cloud-native platform aims to unite factory floors and IT, paving the way for more agile and ultimately autonomous manufacturing.

Destra's fund is boosting distributions by over 21%. We dissect the proprietary strategy driving this yield and the risks investors must consider.

A new partnership is using AI to make 'living drugs' smarter and more effective, promising to revolutionize manufacturing and bring hope to patients.

Moving past generic platforms, specialized AI is generating measurable results in micro-industries, from reducing claim denials to slashing network downtime.

A new oral drug could eliminate the dangerous side effects of CAR T-Cell therapy, potentially making the breakthrough cancer treatment safer and more accessible.

A new $500M USACE contract shows how Tetra Tech is turning advanced AI and data analytics into profitable solutions for America's toxic waste problems.

Secure identity firm CLEAR lands a major CMS contract to overhaul Medicare.gov's login system, signaling a strategic push into the government sector.

A startup claims to solve AI's 95% pilot failure rate with a self-improving engine. We analyze if this is the key to unlocking true enterprise AI.